To: MEDICAL EDITORS
Contact: HHS Press Office, +1-202-690-6343
WASHINGTON, April 17 /PRNewswire-USNewswire/ — The approval by
the Food and Drug Administration (FDA) of the first U.S. H5N1
influenza vaccine for use in humans is a sign of progress in our
ongoing efforts to protect the American people from a pandemic. We
have the opportunity to be the first generation that prepares for a
pandemic, and we are working to that meet that challenge.
To date, H5N1 avian influenza has remained primarily an animal
disease, but should the virus acquire the ability for sustained
transmission among humans, …
Read the rest of this article with a Free Trial at HighBeam Research.
Information provided by: Findarticles.com










